Den europeiske union -
norsk -
EMA (European Medicines Agency)
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyomer - hypofysiske og hypotalamiske hormoner og analoger - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
orgovyx
accord healthcare s.l.u. - relugolix - prostata neoplasmer - endokrin terapi - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
Norge -
norsk -
Statens legemiddelverk
ryeqo
2care4 aps - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg
Norge -
norsk -
Statens legemiddelverk
ryeqo
orifarm as - relugoliks / Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 40 mg / 1 mg / 0.5 mg
Norge -
norsk -
Statens legemiddelverk
prascend 1 mg
boehringer ingelheim vetmedica gmbh - pergolidmesilat - tablett - 1 mg
Norge -
norsk -
Statens legemiddelverk
pergoquin 1 mg
vetviva richter gmbh - pergolidmesilat - tablett - 1 mg
Norge -
norsk -
Statens legemiddelverk
pergosafe 0.5 mg
alfasan nederland b.v. - pergolidmesilat - tablett, filmdrasjert - 0.5 mg
Norge -
norsk -
Statens legemiddelverk
pergosafe 1 mg
alfasan nederland b.v. - pergolidmesilat - tablett, filmdrasjert - 1 mg
Norge -
norsk -
Statens legemiddelverk
prasequin vet 1 mg
cp-pharma handelsgesellschaft mbh - pergolidmesilat - tablett - 1 mg
Norge -
norsk -
Statens legemiddelverk
finilac vet 50 mikrog/ ml
le vet beheer b.v. - kabergolin - mikstur, oppløsning - 50 mikrog/ ml